Literature DB >> 29432031

Deferred diagnosis in children assessed for fetal alcohol spectrum disorder.

Katherine Flannigan1, Kamaldeep Gill2, Jacqueline Pei2, Gail Andrew3, Hasu Rajani3, Audrey McFarlane4, Teresa O'Riordan5, Brent Symes2, Carmen Rasmussen3.   

Abstract

Early intervention for individuals with FASD is paramount, thus exploring factors that affect the diagnostic process is critical. This process can be complicated by challenges gathering background information, accurately evaluating higher-level cognitive skills across ages, and teasing apart the impact of life adversities from the effects of prenatal alcohol exposure. This study is a retrospective file review of 154 children (44% female; mean age 8.4 years, range 1.0 to 16.9) deferred at their first FASD assessment, and 51 (43% female; mean 9.9 years, range 2.7 to 17.2) who returned for a second assessment. Data was collected from three Canadian FASD clinics to explore reasons for deferral, the clinical profile of deferred children, why some returning children were diagnosed while others were not, and changes between assessments. Results suggest that deferred children initially lacked evidence of abnormalities sufficient for a diagnosis, presented with areas of relative neurobehavioral strength and difficulty, and children eventually diagnosed with FASD showed significantly more impaired brain function (p < 0.001, ηp2 = 0.547), postnatal risk (p = 0.021, ηp2 = 0.121), and comorbidities (p = 0.038, ηp2 = 0.085) than undiagnosed children. These findings provide important insights into the process of clinical assessment for FASD.

Entities:  

Keywords:  Assessment; Fetal Alcohol Spectrum Disorder; children; deferral; diagnosis

Year:  2018        PMID: 29432031     DOI: 10.1080/21622965.2018.1427094

Source DB:  PubMed          Journal:  Appl Neuropsychol Child        ISSN: 2162-2965            Impact factor:   1.493


  2 in total

1.  Trajectories of brain white matter development in young children with prenatal alcohol exposure.

Authors:  Preeti Kar; Jess E Reynolds; William Ben Gibbard; Carly McMorris; Christina Tortorelli; Catherine Lebel
Journal:  Hum Brain Mapp       Date:  2022-05-21       Impact factor: 5.399

2.  The cost-effectiveness of screening tools used in the diagnosis of fetal alcohol spectrum disorder: a modelled analysis.

Authors:  Patrick Berrigan; Gail Andrew; James N Reynolds; Jennifer D Zwicker
Journal:  BMC Public Health       Date:  2019-12-27       Impact factor: 3.295

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.